-
-
-
-
-
-
-
Intelligent Bio Solutions to Participate in Noble Capital Markets' 21st Annual Emerging Growth Equity Conference on December 2-3, 2025
-
-
-
-
-
-
-
Intelligent Bio Solutions collects data to strengthen FDA submission
-
-
-
-
-
-
-
Intelligent Bio Solutions' (INBS) FDA Clearance Process Remains on Track for 2025 U.S. Launch
-
-
-
-
-
-
-
Intelligent Bio Solutions (INBS) Adds Quantum TM to 400+ Account Portfolio Utilizing Breakthrough Fingerprint Drug Testing
-
-
-
-
-
-
-
Intelligent Bio Solutions (INBS) Announces Adoption of its Non-Invasive Drug Screening Solution by Global Engineering Leader, Pyrotek
-
-
-
-
-
458,935 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

